- Home
- KALV vs DDL Comparison
KALV vs DDL Comparison
Compare KALV & DDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- DDL
- Stock Information
- Founded
- KALV N/A
- DDL 2014
- Country
- KALV United States
- DDL China
- Employees
- KALV N/A
- DDL N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- DDL Catalog/Specialty Distribution
- Sector
- KALV Health Care
- DDL Consumer Discretionary
- Exchange
- KALV Nasdaq
- DDL Nasdaq
- Market Cap
- KALV 551.2M
- DDL 450.9M
- IPO Year
- KALV N/A
- DDL 2021
- Fundamental
- Price
- KALV $13.62
- DDL $1.71
- Analyst Decision
- KALV Strong Buy
- DDL
- Analyst Count
- KALV 8
- DDL 0
- Target Price
- KALV $26.43
- DDL N/A
- AVG Volume (30 Days)
- KALV 1.2M
- DDL 726.6K
- Earning Date
- KALV 11-10-2025
- DDL 11-12-2025
- Dividend Yield
- KALV N/A
- DDL N/A
- EPS Growth
- KALV N/A
- DDL 9.48
- EPS
- KALV N/A
- DDL 0.14
- Revenue
- KALV $1,426,000.00
- DDL $3,374,301,331.00
- Revenue This Year
- KALV N/A
- DDL $7.94
- Revenue Next Year
- KALV $234.65
- DDL $10.37
- P/E Ratio
- KALV N/A
- DDL $12.07
- Revenue Growth
- KALV N/A
- DDL 8.43
- 52 Week Low
- KALV $7.30
- DDL $1.65
- 52 Week High
- KALV $17.28
- DDL $4.79
- Technical
- Relative Strength Index (RSI)
- KALV 70.91
- DDL 40.80
- Support Level
- KALV $10.55
- DDL $1.65
- Resistance Level
- KALV $13.44
- DDL $1.83
- Average True Range (ATR)
- KALV 0.65
- DDL 0.08
- MACD
- KALV 0.36
- DDL -0.00
- Stochastic Oscillator
- KALV 94.79
- DDL 26.67
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.
About DDL Dingdong (Cayman) Limited (each two representing three)
Dingdong (Cayman) Ltd is the fastest growing on-demand e-commerce company in China. The company directly provides users and households with fresh produce, meat and seafood, and other daily necessities through a convenient shopping experience supported by an extensive self-operated frontline fulfillment grid. It recognizes revenues from product sales of fresh groceries and other daily necessities through Dingdong Fresh APP and mini-programs and membership services.